S&P/ASX 200 Index (ASX: XJO) shares rallied strongly today as investors looked beyond the Iran war and oil price shock.
ASX 200 shares soared 2.6% to an intraday peak of 8,804 points in morning trading on Tuesday.
Leading the market today are Guzman Y Gomez Ltd (ASX: GYG) shares, up 18%, and Nextdc Ltd (ASX: NXT), up 12%.
However, some ASX shares are bucking the trend.
Here are six stocks that hit 52-week lows today.
Image source: Getty Images
Sonic Healthcare Ltd (ASX: SHL)
Sonic Healthcare is one of several ASX healthcare shares trading at multi-year lows these days.
The sector faces multiple headwinds, including currency changes, US tariffs, and higher labour costs and other expenses.
The Sonic Healthcare share price fell to a decade-low of $18.88 today.
This ASX healthcare share has fallen 13% in the year to date (YTD) and 21% over the past year.
Ord Minnett has a hold rating on Sonic Healthcare with a 12-month share price target of $24.
Stockland Corp Ltd (ASX: SGP)
The Stockland share price fell to a 52-week low of $4.01 today.
Stockland shares are down 30% YTD.
In a separate article, my colleague Aaron has delved into the reasons this ASX property share has tanked in 2026.
Macquarie has just reiterated its buy rating on Stockland shares with a target price of $4.42.
Endeavour Group Ltd (ASX: EDV)
The Endeavour share price fell to a record low of $3.13 on Tuesday.
Endeavour shares have tumbled 14% YTD.
Citi recently downgraded this ASX consumer staples share to a hold rating.
The broker reduced its 12-month target from $4.30 to $3.70.
Atlas Arteria Group Ltd (ASX: ALX)
The Atlas Arteria share price fell to a nine-year low of $4.21 today.
Shares in the toll roads operator have fallen 13% YTD.
Last week, Morgan Stanley maintained its hold rating on Atlas Arteria shares.
The broker reduced its share price target from $5.06 to $4.96.
Lendlease Group (ASX: LLC)
The Lendlease share price dropped to an all-time low of $3.10 on Tuesday.
The ASX real estate share has fallen 39% in 2026.
Today, Macquarie reiterated its buy rating with a 12-month price target of $4.99.
Healius Ltd (ASX: HLS)
The Healius share price dropped to a record low of 51 cents today.
The ASX healthcare share has declined 43% YTD.
Goldman Sachs reiterated its sell rating on Healius shares last month.
The broker lowered its price target from 66 cents to 57 cents.
